The complaint centers on allegations that Hyliion’s leadership orchestrated a scheme to inflate stock prices through deceptive disclosures. Specifically, the lawsuit claims the company announced a partnership with a shell entity lacking actual operations to trigger rapid market appreciation. According to the filing, this artificial price surge was timed to benefit individual defendants through insider trading, leaving retail investors with diminished holdings once the true nature of the business prospects emerged.

Shareholders who purchased stock during the designated class period are not required to take immediate action to remain part of the collective group, though those seeking to lead the litigation must contact the firm by the late October deadline. The legal team is currently reviewing claims from individuals who believe their investment decisions were based on materially false information provided by Hyliion executives during the spring of 2026.